Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Liz is Science Editor for Cancer Health, POZ, Hep and Real Health. She has been a health journalist and medical editor for more than 20 years, covering HIV, viral hepatitis, cancer and other health issues.
Pairing low-income and minority cancer patients with community health workers improved quality of life.
Many people who received any of the authorized COVID-19 vaccines are now eligible for an additional dose of their choice.
Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.
Some studies suggest aspirin therapy may also help lower the risk of colorectal cancer.
Powell had received treatment for multiple myeloma, which can lead to poorer response to COVID-19 vaccines.
Immunotherapy plus chemotherapy improved overall survival in people with persistent, recurrent or metastatic cervical cancer.
Cancer research has seen enormous strides in the past 50 years, but disparities persist and COVID-19 has led to setbacks.
Molnupiravir reduces severe illness and death, but it must be started within days after developing symptoms.
Long-awaited results from the ANCHOR study suggest screening to detect precancerous lesions should be part of routine care.
Imfinzi plus chemotherapy led to a modest but significant improvement in overall survival.
The antibody-drug conjugate Tivdak led to remission in 24% of cervical cancer patients.
Keytruda plus chemotherapy reduced the risk of death by 27% in people with locally advanced or metastatic disease.
The committee voted against third shot for all adults, however, casting doubts on Biden’s booster plan.
Exkivity is approved for adults with advanced non-small-cell lung cancer with specific EGFR mutations.
People who sit less and do any amount of physical activity gain some health benefits.
COVID-19 vaccines are safe for people with cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.